Keros Therapeutics (KROS) Net Cash Flow (2019 - 2026)
Keros Therapeutics (KROS) recorded Net Cash Flow of -$406.06 million in Q4 2025, compared with $29.25 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Net Cash Flow (2019 - 2026) Analysis & Trends
For FY2025, Keros Therapeutics reported Net Cash Flow of -$272.52 million.
- Across earlier years, Net Cash Flow came in at $229.02 million in FY2024 (+340.6%), $51.98 million in FY2023 (+6.1%), $49.01 million in FY2022 and -$34.62 million in FY2021.
- The Q4 2025 figure is the lowest quarterly Net Cash Flow in data going back to Q1 2019.
- On a year-over-year basis, Net Cash Flow rose in two of the last four quarters, with an average decline of 7.9%.
- Per Business Quant, the preceding three quarters came in at $3.26 million (Q3 2025), -$30.33 million (Q2 2025) and $160.61 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -4.12 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.21 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.81 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.41 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -799.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.26 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 843.00 Mn |
| 10 | Keros Therapeutics | 185.02 Mn | -900.96 Mn | - | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.86 Mn |
| Jun 30, 2026 | -23.89 Mn |
| Mar 31, 2026 | -5.92 Mn |
| Dec 31, 2025 | -406.06 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | -30.33 Mn |
| Mar 31, 2025 | 160.61 Mn |
| Dec 31, 2024 | 29.25 Mn |
| Sep 30, 2024 | 125.06 Mn |
| Jun 30, 2024 | -36.58 Mn |
| Mar 31, 2024 | 111.30 Mn |
| Dec 31, 2023 | 43.25 Mn |
| Sep 30, 2023 | -34.25 Mn |
| Jun 30, 2023 | -29.40 Mn |
| Mar 31, 2023 | 72.38 Mn |
| Dec 31, 2022 | 39.62 Mn |
| Sep 30, 2022 | 23.81 Mn |
| Jun 30, 2022 | -12.97 Mn |
| Mar 31, 2022 | -1.46 Mn |
| Dec 31, 2021 | 8.69 Mn |
API Access
Keros Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();